news
FDA approves Gazyva to treat follicular lymphoma
1 March 2016 | By Victoria White
The FDA has approved Gazyva (obinutuzumab) plus bendamustine chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma...
List view / Grid view
Genentech
news
FDA grants third venetoclax Breakthrough Therapy Designation
28 January 2016 | By Victoria White
The designation is for venetoclax in combination with HMAs for the treatment of patients with untreated AML who are ineligible to receive standard induction therapy...
news
FDA approves Tarceva (Erlotinib) tablets for specific type of lung cancer
15 May 2013 | By Astellas Pharma Inc.
The FDA also approved the cobas® EGFR Mutation Test, which was developed by Roche and validated in the pivotal EURTAC study...
news
Gilead Sciences to purchase biologics process research and clinical manufacturing facility from Genentech
8 August 2011 | By Gilead Sciences Inc
Gilead Sciences, Inc. has signed a definitive agreement...
